🎉 M&A multiples are live!
Check it out!

Aarti Pharmalabs Valuation Multiples

Discover revenue and EBITDA valuation multiples for Aarti Pharmalabs and other public comps.

See Aarti Pharmalabs Valuation Multiples

Aarti Pharmalabs Overview

About Aarti Pharmalabs

Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.


Founded

2019

HQ

India
Employees

2.1K+

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$786M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Aarti Pharmalabs Financials

Aarti Pharmalabs has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Aarti Pharmalabs achieved revenue of $210M and an EBITDA of $45.1M.

Aarti Pharmalabs expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Aarti Pharmalabs valuation multiples based on analyst estimates

Aarti Pharmalabs P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $138M $223M $210M n/a XXX
Gross Profit $36.0M $61.2M $80.9M XXX XXX
Gross Margin 26% 27% 39% XXX XXX
EBITDA $22.8M $39.6M $45.1M n/a XXX
EBITDA Margin 17% 18% 22% NaN% XXX
Net Profit $14.1M $22.3M $25.0M XXX XXX
Net Margin 10% 10% 12% XXX XXX
Net Debt $29.5M $21.9M $27.8M XXX XXX

Financial data powered by Morningstar, Inc.

Aarti Pharmalabs Stock Performance

As of February 14, 2025, Aarti Pharmalabs's stock price is INR 720 (or $8).

Aarti Pharmalabs has current market cap of INR 65.3B (or $753M), and EV of INR 68.1B (or $786M).

See Aarti Pharmalabs trading valuation data

Aarti Pharmalabs Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$786M $753M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Aarti Pharmalabs Valuation Multiples

As of February 14, 2025, Aarti Pharmalabs has market cap of $753M and EV of $786M.

Aarti Pharmalabs's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Aarti Pharmalabs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Aarti Pharmalabs and 10K+ public comps

Aarti Pharmalabs Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $786M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Aarti Pharmalabs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Aarti Pharmalabs Valuation Multiples

Aarti Pharmalabs's NTM/LTM revenue growth is n/a

Aarti Pharmalabs's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $21K for the same period.

Over next 12 months, Aarti Pharmalabs's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Aarti Pharmalabs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Aarti Pharmalabs and other 10K+ public comps

Aarti Pharmalabs Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -6% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 14% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $21K XXX XXX XXX XXX
S&M Expenses to Revenue 4% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 0% XXX XXX XXX XXX
Opex to Revenue 21% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Aarti Pharmalabs Public Comps

See valuation multiples for Aarti Pharmalabs public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Jubilant Pharmova XXX XXX XXX XXX XXX XXX
Biocon XXX XXX XXX XXX XXX XXX
Syngene International XXX XXX XXX XXX XXX XXX
Dishman Carbogen Amics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Aarti Pharmalabs M&A and Investment Activity

Aarti Pharmalabs acquired  XXX companies to date.

Last acquisition by Aarti Pharmalabs was  XXXXXXXX, XXXXX XXXXX XXXXXX . Aarti Pharmalabs acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Aarti Pharmalabs

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Aarti Pharmalabs

When was Aarti Pharmalabs founded? Aarti Pharmalabs was founded in 2019.
Where is Aarti Pharmalabs headquartered? Aarti Pharmalabs is headquartered in India.
How many employees does Aarti Pharmalabs have? As of today, Aarti Pharmalabs has 2.1K+ employees.
Is Aarti Pharmalabs publicy listed? Yes, Aarti Pharmalabs is a public company listed on BOM.
What is the stock symbol of Aarti Pharmalabs? Aarti Pharmalabs trades under 543748 ticker.
When did Aarti Pharmalabs go public? Aarti Pharmalabs went public in 2023.
Who are competitors of Aarti Pharmalabs? Similar companies to Aarti Pharmalabs include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics.
What is the current market cap of Aarti Pharmalabs? Aarti Pharmalabs's current market cap is $753M
What is the current revenue growth of Aarti Pharmalabs? Aarti Pharmalabs revenue growth between 2023 and 2024 was -6%.
Is Aarti Pharmalabs profitable? Yes, Aarti Pharmalabs is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.